Leptin stimulates esophageal adenocarcinoma growth by nonapoptotic mechanisms

American Journal of Surgery

Volumn 186, Issue 5, 2003, Pages 575-578

  Somasundar, Ponnandai ^a,b   Riggs, Dale ^a,b   Jackson, Barbara ^a,b   Vona Davis, Linda ^a,b   McFadden, David W ^a,b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Barrett's associated esophageal adenocarcinoma; Leptin

Indexed keywords

RECOMBINANT LEPTIN;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HORMONE ACTION; HUMAN; HUMAN CELL; NECROSIS; PRIORITY JOURNAL;

EID: 0242329861     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2003.07.017     Document Type: Article

References (34)

1. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
2. Caro J.F., Sinha M.K., Kolaczynski J.W., et al. Leptin the tale of an obesity gene . Diabetes. 45:1996;1455-1462.
3. Ganong WF, Martini L, Chow WH, et al. Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. Cancer Epidemiol Biomarkers Prev 1997;6:481-5.
4. Park H.Y., Kwon H.M., Lim H.J., et al. Potential role of leptin in angiogenesis leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro . Exp Mol Med. 33:2001;95-102.
5. Oda A., Taniguchi T., Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci. 47:2001;141-150.
6. Hardwick J.C., Van Den Brink G.R., Offerhaus G.J., et al. Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 121:2001;79-90.
7. Liu Z., Uesaka T., Watanabe H., Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol. 19:2001;1009-1014.
8. Laud K., Gourdou I., Pessemesse L., et al. Identification of leptin receptors in human breast cancer functional activity in the T47-D breast cancer cell line . Mol Cell Endocrinol. 188:2002;219-226.
9. Dieudonne M.N., Machinal-Quelin F., Serazin-Leroy V., et al. Leptin mediates a proliferative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun. 293:2002;622-628.
10. Blot W.J., Devesa S.S., Kneller R.W., Fraumeni J.F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
11. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053.
12. Chow W.H., Blot W.J., Vaughan T.L., et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 90:1998;150-155.
13. Soldes O.S., Kuick R.D., Thompson I.A., et al. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer. 79:1999;595-603.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays . J Immunol Meth. 65:1983;55-63.
15. Bollschweiler E., Wolfgarten E., Gutschow C., Holscher A.H. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer. 92:2001;549-555.
16. Lagergren J., Bergstrom R., Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 130:1999;883-890.
17. Lagergren J., Bergstrom R., Nyren O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut. 47:2000;26-29.
18. Halaas J.L., Gajiwala K.S., Maffei M., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
19. Campfield L.A., Smith F.J., Guisez Y., et al. Recombinant mouse OB protein evidence for a peripheral signal linking adiposity and central neural networks . Science. 269:1995;546-549.
20. Ahima R.S., Prabakaran D., Mantzoros C., et al. Role of leptin in the neuroendocrine response to fasting. Nature. 382:1996;250-252.
21. Montague C.T., Farooqi I.S., Whitehead J.P., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387:1997;903-908.
22. Frederich R.C., Hamann A., Anderson S., et al. Leptin levels reflect body lipid content in mice evidence for diet-induced resistance to leptin action . Nat Med. 1:1995;1311-1314.
23. Maffei M., Halaas J., Ravussin E., et al. Leptin levels in human and rodent measurement of plasma leptin and ob RNA in obese and weight-reduced subjects . Nat Med. 1:1995;1155-1161.
24. Considine R.V., Sinha M.K., Heiman M.L., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:1996;292-295.
25. Somasundar P, Yu A, Vona-Davis L, McFadden DW. Differential responses of leptin on cancer in vitro. 36th Annual Meeting of the Association for Academic Surgery, Boston, Massachuestts, 2002, program abstract P82.331.
26. Attoub S., Noe V., Pirola L., et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 14:2000;2329-2338.
27. Schneider R., Bornstein S.R., Chrousos G.P., et al. Leptin mediates a proliferative response in human gastric mucosa cells with functional receptor. Horm Metab Res. 33:2001;1-6.
28. Gordeladze J.O., Drevon C.A., Syversen U., Reseland J.E. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization impact on differentiation markers, apoptosis, and osteoclastic signaling . J Cell Biochem. 85:2002;825-836.
29. Okuya S., Tanabe K., Tanizawa Y., Oka Y. Leptin increases the viability of isolated rat pancreatic islets by suppressing apoptosis. Endocrinology. 142:2001;4827-4830.
30. Tsai T.T., Bongiorno P.F., Orringer M.B., Beer D.G. Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus. Cancer Detect Prev. 21:1997;326-331.
31. Renehan A.G., Booth C., Potten C.S. What is apoptosis, and why is it important? BMJ. 322:2001;1536-1538.
32. Martin K., Kirkwood T.B., Potten C.S. Age changes in stem cells of murine small intestinal crypts. Exp Cell Res. 241:1998;316-323.
33. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
34. Souza R.F., Shewmake K., Beer D.G., et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res. 60:2000;5756-5772.